Literature DB >> 9437615

Do individuals with substance abuse diagnoses incur higher charges than individuals with other chronic conditions?

D W Garnick1, A M Hendricks, C Comstock, C Horgan.   

Abstract

Concerns about high costs have led to limits on the services covered by most insurance plans for substance abuse treatment. But, the commonly used comparison group for cost analyses, all enrollees in a health-care plan, may not be appropriate because addiction is a chronic condition. Therefore, to determine whether substance abusers incur higher charges than patients with other serious chronic conditions, we used health insurance information for employees and dependents over 3 years (1989 to 1991) for two firms with a total of almost 40,000 employees to do alternate comparisons. We compared average annual charges for patients with the following diagnoses: substance abuse, substance abuse with mental illness, arthritis, asthma, and diabetes. Patients who undergo treatment for abusing alcohol, drugs, or both often (but not always) incur higher charges than people with other chronic conditions. Clear differences in average charges emerge between patients with and without mental health claims.

Entities:  

Mesh:

Year:  1997        PMID: 9437615     DOI: 10.1016/s0740-5472(97)00137-2

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  3 in total

1.  Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders.

Authors:  Melanie E Bennett; Alan S Bellack; Clayton H Brown; Carlo DiClemente
Journal:  Addict Behav       Date:  2009-03-27       Impact factor: 3.913

2.  Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes.

Authors:  Ranjana Banerjea; Usha Sambamoorthi; David Smelson; Leonard M Pogach
Journal:  J Behav Health Serv Res       Date:  2008-05-30       Impact factor: 1.475

3.  Chronic disease and recent addiction treatment utilization among alcohol and drug dependent adults.

Authors:  Sharon Reif; Mary Jo Larson; Debbie M Cheng; Donald Allensworth-Davies; Jeffrey Samet; Richard Saitz
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.